The effects of the proton pump inhibitor esomeprazole alone or in combination with Coca-Cola on the absorption of Capecitabine in patients with colorectal cancer or other solid tumours ' the COCA study' [Het effect van de protonpompremmeresomeprazol op de absorptie van capecitabine bij patiËnten met colorectaal carcinomen of andere type solide tumoren 'de COCA study']

Trial Profile

The effects of the proton pump inhibitor esomeprazole alone or in combination with Coca-Cola on the absorption of Capecitabine in patients with colorectal cancer or other solid tumours ' the COCA study' [Het effect van de protonpompremmeresomeprazol op de absorptie van capecitabine bij patiËnten met colorectaal carcinomen of andere type solide tumoren 'de COCA study']

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2018

At a glance

  • Drugs Capecitabine (Primary) ; Esomeprazole (Primary)
  • Indications Colorectal cancer; Solid tumours
  • Focus Pharmacokinetics
  • Acronyms COCA-study
  • Most Recent Events

    • 06 Mar 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top